Achieve Life Sciences Inc
Change company Symbol lookup
Select an option...
ACHV Achieve Life Sciences Inc
CIG Companhia Energetica de Minas Gerais CEMIG
VIVC Vivic Corp
DLMAF Dollarama Inc
RNDB Randolph Bancorp Inc
DQ Daqo New Energy Corp
KTHN Katahdin Bankshares Corp
SZC The Cushing? Renaissance Fund Common
SRV Cushing? MLP & Infrastructure Total Return Fund
SRF The Cushing? Energy Income Fund Common
Go

Health Care : Biotechnology | Small Cap ValueCompany profile

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company engaged in the development and commercialization of cytisine for smoking cessation. The Company’s focus is to address the global smoking health epidemic, which is the leading cause of preventable death and is responsible for nearly six million deaths annually worldwide. Cytisine is an established 25 day smoking cessation treatment that has been approved and marketed in Central and Eastern Europe by a third party for over 20 years under the brand name TabexTM. As of December 2016, it is estimated that over 21 million people have used cytisine to help combat nicotine addiction, including over 2,000 patients in investigator-conducted, Phase III clinical trials in Europe and New Zealand.

Closing Price
$2.98
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
1,761,306
0
  • Prev Close
    2.98
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    1.8M
  • Last (time)
    3:59p ET 03/21/19
  • Last (size)
    100
  • 52-Wk Range
    1.04 - 14.60
    LowHigh
  • (05/07/18 - 12/21/18)
    185.19%
  • 122.2%
  • Market Cap
    20.0M
  • Shares Outstanding
    6.7M
  • -5.51
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 2.8
  • 26.69
  • (% of float 02/28/19)
    17.24

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.